GWPH News and Press, GW Pharmaceuticals Plc From 02/10/20

As the CBD pet market skyrockets to $1.7 billion by 2023, as projected by Brightfield Group, CBD companies that focus on this market are seeing opportunities selling to owners of pets, such as horses, cats and dogs. Offering a variety of pet chews, oils and equine products, CBD Unlimited, Inc....

As CBD gains acceptance among consumers and in brick-and-mortar stores as well as online sites, travel is now becoming an important growth area. CBD travel products extend impact of CBD appeal for upscale consumers as companies grow such as CBD Unlimited, Inc. (OTC PINK: EDXC ). CBD trave...

Zogenix (NASDAQ: ZGNX) reported what it called "positive" results from a late-stage clinical trial testing its drug candidate, Fintepla, in patients with a variety of childhood-onset epilepsy called Lennox-Gastaut syndrome. And technically, the company was right: Fintepla reduced the median ...

Volatility is something that is to be expected within pot stocks . One of the key factors to this is that the industry has only been around for a few years at this point. Because of its infancy, oftentimes investors are investing off of speculation rather than intrinsic or future value that a g...

CBD companies are aggressive when it comes to expanding into foreign markets. CBD expands into foreign markets for more growth for companies such as CBD Unlimited, Inc. (OTC PINK: EDXC). Countries such as South Africa, Jamaica and Puerto Rico have been active markets for CBD Unlimited, Inc.&#x...

Zogenix (NASDAQ: ZGNX ) slumps  33%  after hours in reaction to its announcement of "successful" results from a Phase 3 clinical trial evaluating two doses of Fintepla (fenfluramine oral solution) (ZX008) in patients with a severe form of childhood-onset epilepsy called Lennox-...

CBD and hemp regulations have improved, but they remain in flux and confusing for growing industry companies such as CBD Unlimited, Inc. (OTC PINK: EDXC ). Late last month, the U.S. Department of Agriculture (USDA) lengthened its public comments period on new regulations — but state ...

As CBD enters second generation 2.0 in terms of branding, packaging, quality enforcement, regulation and marketing, the acceptance of CBD products by mainstream consumers and retailers is taking a unique turn. Partnership between CBD companies and prominent retailers is a new tool within the C...

After an underwhelming 2019, shares of GW Pharmaceuticals (NASDAQ: GWPH)  perked up nicely in January, with the drugmaker's stock jumping 10% for the month, according to data from  S&P Global Market Intelligence . The gain last month came in response to the company's prelim...

CBD companies with solid, seasoned management executives are seen as faring best in the fast-moving CBD product marketplace. Todd Davis, CEO and Chairman of CBD Unlimited, Inc. (OTC PINK: EDXC) has been in this position since 2003. He has pioneered the growth of this company as a leading ...